本页面由Tiger Trade Technology Pte. Ltd.提供服务

Pandion Therapeutics Inc.

60.05
0.0000
成交量:- -
成交额:- -
市值:17.04亿
市盈率:-18.92
高:60.05
开:60.05
低:60.05
收:60.05
52周最高:62.90
52周最低:10.28
股本:2,838.19万
流通股本:562.73万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-3.1737
每股收益(LYR):-3.1737
净资产收益率:-34.81%
总资产收益率:-19.05%
市净率:7.94
市盈率(LYR):-18.92

数据加载中...

2021/05/17

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/08

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/01

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/04/01

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/04/01

重要事件披露

8-K - Current report
2021/04/01

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/03/31

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/12

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/02/25

重要事件披露

8-K - Current report
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/04

重要事件披露

8-K - Current report
2020/12/03

重要事件披露

8-K - Current report
2020/11/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]